Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]Adavosertib
Clinical trial NCT05008913 · TERMINATED
Trial details
- NCT number
- NCT05008913
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2021-11-16
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.